• Join
  • Login
  • Contact

Search abstracts

Challenges in preclinical characterization of nanomedicines

  • In: SYMPOSIUM: SAFETY OF NANOMEDICINES: REALITY CHECK? on Tuesday, 15 April 2014, 13:00-14:30
  • At: PSWC, Melbourne (Australia) (2014)
  • Type: Presentation
  • By: DOBROVOLSKAIA, Marina (Leidos Biomedical Research Inc, Frederick National Laboratory for Cancer Researc, CRTP/NCL, Frederick, md, United States of America)
  • Abstract:

    Background: Nanomedicine is rapidly growing field. Many nanoformulations have been granted regulatory approval for use in medical applications, while many more are in various phases of preclinical and clinical development. Aims: To review experience of NCI-Nanotechnology Characterization Laboratory with preclinical characterization of


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses